Clozapine augmentation for treatment-resistant schizoaffective disorder-Reference-Cited by-同舟云学术

Clozapine augmentation for treatment-resistant schizoaffective disorder

Published:2016-03-04 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Lally John¹,Tully John²,MacCabe James H¹

Affiliation:

1. Institute of Psychiatry, Psychology and Neuroscience, King's College London; Department of Psychosis Studies; De Crespigny Park London UK SE5 8AF

2. Institute of Psychiatry, Psychology and Neuroscience; Department of Forensic and Neurodevelopmental Sciences; De Crespigny Park London UK SE5 8AF

Publisher

Wiley

Subject

Pharmacology (medical)

Reference51 articles.

1. Detecting skewness from summary information;Altman;BMJ,1996

2. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up;Banov;The Journal of Clinical Psychiatry,1994

3. What is a "mood stabilizer"? An evidence-based response;Bauer;The American Journal of Psychiatry,2004

4. Statistics notes. Trials randomised in clusters;Bland;BMJ,1997

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicriteria credit scoring model for SMEs using hybrid BWM and TOPSIS;Financial Innovation;2021-10-08

2. Clozapine (generic versus branded) for people with schizophrenia;Cochrane Database of Systematic Reviews;2019-01-24

3. Clozapine versus risperidone for people with schizophrenia;Cochrane Database of Systematic Reviews;2018-12-10

4. Clozapine versus quetiapine for people with schizophrenia;Cochrane Database of Systematic Reviews;2018-12-09

5. Clozapine versus olanzapine for people with schizophrenia;Cochrane Database of Systematic Reviews;2018-12-07